Dihydromyricetin attenuates fibrosis-associated features of hypertrophic scar with accompanying changes in PI3K/AKT/mTOR-related signaling

Peng Cao, Ao Shi, Yunwei Wang, Shuoyi Hui, Guozhong Lyu

Open source

DOI
10.3389/fphar.2026.1862651
Published
2026-08-12
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1862651,
  title = {Dihydromyricetin attenuates fibrosis-associated features of hypertrophic scar with accompanying changes in PI3K/AKT/mTOR-related signaling},
  author = {Peng Cao and Ao Shi and Yunwei Wang and Shuoyi Hui and Guozhong Lyu},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1862651},
  url = {https://doi.org/10.3389/fphar.2026.1862651}
}

RIS

TY  - JOUR
TI  - Dihydromyricetin attenuates fibrosis-associated features of hypertrophic scar with accompanying changes in PI3K/AKT/mTOR-related signaling
AU  - Peng Cao
AU  - Ao Shi
AU  - Yunwei Wang
AU  - Shuoyi Hui
AU  - Guozhong Lyu
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1862651
UR  - https://doi.org/10.3389/fphar.2026.1862651
ER  - 

APA

Cao, P., Shi, A., Wang, Y., Hui, S., & Lyu, G. (2026). Dihydromyricetin attenuates fibrosis-associated features of hypertrophic scar with accompanying changes in PI3K/AKT/mTOR-related signaling. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1862651

Source records